10 mg \/ ml concentrate for solution for infusion
vinorelbine<\/p>\n\n\n\n
Navirel is a concentrated solution for\u00a0infusion.\u00a0The active substance vinorelbine belongs to a group of medicines used to treat cancer.\u00a0These drugs are called\u00a0cytostatics, or cell inhibitors because they delay or prevent the growth of cancer cells.\u00a0Navirel is used to treat certain types of lung cancer (so-called non-small cell lung cancer\u00a0) and breast cancer.<\/p>\n\n\n\n
Vinorelbine contained in Navirel may also be approved for the treatment of other conditions not mentioned in this product information.\u00a0Ask your doctor, pharmacist, or other healthcare professionals if you have any further questions, and always follow their instructions.<\/p>\n\n\n\n
Talk to your doctor, pharmacist, or nurse before receiving Navirel<\/p>\n\n\n\n
Carefully avoid all contact with the eyes. There is a risk of severe irritation and even sores on the eye (corneal ulcers). In case of contact with eyes, rinse immediately with sodium chloride solution.<\/p>\n\n\n\n
In case of a burning sensation in the infusion area during or after\u00a0infusion\u00a0one, inform a doctor immediately.\u00a0This may be a sign of an injection error.\u00a0Infusion\u00a0must be stopped immediately.<\/p>\n\n\n\n
This medicine is not recommended for use in children as there are insufficient data on the safety and efficacy in children.<\/p>\n\n\n\n
Tell your doctor, pharmacist, or nurse if you are taking, have recently taken, or might take any other medicines.<\/p>\n\n\n\n
Your doctor should pay special attention if you are taking the following medicines:<\/p>\n\n\n\n
Live attenuated vaccines (vaccines that contain live virus particles, such as measles vaccine, mumps vaccine, rubella vaccine) are not recommended with Navirel, as they may increase the risk of life-threatening vaccination disease. Because the yellow fever vaccine also contains live virus particles, you must not be given yellow fever vaccines in combination with Navirel.<\/p>\n\n\n\n
You should not be treated with Navirel if you are pregnant unless it has been explicitly prescribed by your doctor.<\/p>\n\n\n\n
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.<\/p>\n\n\n\n
You should not be treated with Navirel if you are breastfeeding.\u00a0If treatment is necessary, you must stop breastfeeding.<\/p>\n\n\n\n
Women should take measures to avoid pregnancy during treatment and for at least three months after stopping treatment by using an effective contraceptive.<\/p>\n\n\n\n
Men receiving treatment must ensure that their partner does not become pregnant during treatment and up to six months after treatment by using an effective contraceptive.<\/p>\n\n\n\n
Advice on sperm preservation should be sought before treatment due to the risk of\u00a0irreversible\u00a0sterility caused by treatment with vinorelbine.<\/p>\n\n\n\n
Side effects\u00a0that may impair your ability to drive and\/or use machines may occur after treatment with vinorelbine.\u00a0If you feel unwell, do not perform tasks that require mental concentration, such as driving or using machines.<\/p>\n\n\n\n
You are responsible for assessing whether you are fit to drive a vehicle or perform work that requires increased attention.\u00a0One of the factors that can affect your ability in these respects is the use of drugs due to their effects and\/or\u00a0side effects.\u00a0Descriptions of these effects and\u00a0side effects\u00a0can be found in other sections.\u00a0Read all the information in this leaflet for guidance.\u00a0If you are not sure, talk to your doctor or pharmacist.<\/p>\n\n\n\n
The preparation and administration of Navirel should only be performed by trained healthcare professionals who specialize in cancer treatment. Navirel is for single use only.<\/strong><\/p>\n\n\n\n Before each treatment, a blood sample will be taken to analyze its constituents to check that you have a sufficient number of\u00a0blood cells\u00a0to be treated with Navirel.\u00a0If the results of this analysis are not satisfactory, your treatment may be postponed and further samples were taken until these values \u200b\u200breturn to normal.<\/p>\n\n\n\n Navirel is usually given once a week. The usual dose for adults is 25-30 mg \/ m\u00b2. Always follow your doctor’s instructions.<\/p>\n\n\n\n Dose adjustment<\/em><\/strong><\/p>\n\n\n\n Navirel should always be <\/strong>injected <\/strong>into a vein.<\/strong><\/p>\n\n\n\n It can be given as an injection for 6 to 10 minutes or as a rapid infusion (drip) for 20 to 30 minutes.<\/p>\n\n\n\n After\u00a0administration, sodium chloride solution will be given as a drip into the same vein so that the drug is distributed.<\/p>\n\n\n\n Your doctor will check that you are getting the right\u00a0dose\u00a0for your illness.\u00a0However, if you are concerned or have symptoms of a possible overdose, such as fever, signs of\u00a0infection,\u00a0or constipation, you should contact a doctor, emergency doctor, or pharmacist.\u00a0<\/p>\n\n\n\n If you have ingested too much medicine or if e.g.\u00a0If a child has ingested the medicine by mistake, contact a doctor or hospital for risk assessment and advice.<\/p>\n\n\n\n If you have any further questions on the use of this product, ask your doctor, pharmacist, or nurse.<\/p>\n\n\n\n Like all medicines, this medicine can cause\u00a0side effects, although not everybody gets them.<\/p>\n\n\n\n Tell your doctor immediately<\/strong> if you get any of the following symptoms, as they may be signs of serious side effects:<\/p>\n\n\n\n Uncommon (may affect up to 1 in 100 people)<\/strong><\/p>\n\n\n\n Rare ( <\/strong>may affect up to 1 in 1,000 people)<\/strong><\/p>\n\n\n\n Has been reported (occurs in an unknown number of users)<\/strong><\/p>\n\n\n\n The following is a list of other side effects that may occur:<\/p>\n\n\n\n Very common (may affect more than 1 user in 10)<\/strong><\/p>\n\n\n\n Common (may affect up to 1 in 10 people)<\/strong><\/p>\n\n\n\n Uncommon (may affect up to 1 in 100 people)<\/strong><\/p>\n\n\n\n Rare (may affect up to 1 in 1,000 people)<\/strong><\/p>\n\n\n\n Very rare (may affect up to 1 in 10,000 people)<\/strong><\/p>\n\n\n\n Has been reported (occurs in an unknown number of users)<\/strong><\/p>\n\n\n\n Burning pain and redness in the infusion area may occur during or after infusion one. As this may be a sign of an injection error, you should inform your doctor or nurse, and the infusion must be stopped immediately.<\/p>\n\n\n\n Keep this medicine out of the sight and reach of children.<\/p>\n\n\n\n Do not use this medicine after the expiry date which is stated on the carton and label after EXP. The expiration date is the last day of the specified month.<\/p>\n\n\n\n Store in a refrigerator (2 \u00b0 C – 8 \u00b0 C). Do not freeze. Store in the original package. Sensitive to light.<\/p>\n\n\n\n Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.<\/p>\n\n\n\n The active substance is vinorelbine (as tartrate), 10 mg\/ml.<\/p>\n\n\n\n One 1 ml vial contains a total of 10 mg of vinorelbine (as tartrate).<\/p>\n\n\n\n One 5 ml vial contains a total of 50 mg of vinorelbine (as tartrate).<\/p>\n\n\n\n The other ingredient is water for injections.<\/p>\n\n\n\n Navirel is a clear, colorless to pale yellow concentrate for solution for infusion (sterile concentrate) supplied in glass vials.<\/p>\n\n\n\n Pack sizes: 1 ml or 5 ml concentrate in packs of 1 or 10 vials.\u00a0Also available as multi-pack with 10 packs, each containing 1\u00a0vial.<\/p>\n\n\n\n Not all pack sizes may be marketed.<\/p>\n\n\n\n medac<\/p>\n\n\n\n Society for clinical<\/p>\n\n\n\n Special preparations mbH<\/p>\n\n\n\n Theater.\u00a06<\/p>\n\n\n\n 22880 Wedel<\/p>\n\n\n\n Germany<\/p>\n\n\n\n Navirel is a concentrate for solution for infusion . The active substance vinorelbine belongs to a group of medicines used to treat cancer. These drugs are called cytostatics , or cell inhibitors, because they delay or prevent the growth of cancer cells. Navirel is used to treat certain types of lung cancer (so-called non- small cell lung cancer ) and breast cancer.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"cybocfi_hide_featured_image":"","footnotes":""},"categories":[2200,15581],"tags":[18626,18621,18622,18625,18617,18620,18623,18618,18624,18619],"class_list":["post-18791","post","type-post","status-publish","format-standard","hentry","category-medicines","category-n","tag-benefits-of-navirel","tag-benefits-of-vinorelbine","tag-navirel","tag-navirel-side-effects","tag-vinorelbine","tag-vinorelbine-side-effects","tag-what-is-navirel","tag-what-is-vinorelbine","tag-what-navirel-is-used-for","tag-what-vinorelbine-is-used-for"],"_links":{"self":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/18791","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/comments?post=18791"}],"version-history":[{"count":4,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/18791\/revisions"}],"predecessor-version":[{"id":18839,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/18791\/revisions\/18839"}],"wp:attachment":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/media?parent=18791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/categories?post=18791"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/tags?post=18791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}If you receive more Navirel than you do in the package leaflet<\/h2>\n\n\n\n
Possible side effects<\/h2>\n\n\n\n
How to store Navirel<\/h2>\n\n\n\n
Contents of the pack and other information<\/h2>\n\n\n\n
Content declaration<\/h2>\n\n\n\n
What the medicine looks like and contents of the pack<\/h2>\n\n\n\n
Marketing Authorization Holder and Manufacturer<\/h2>\n\n\n\n
This medicinal product is authorized under the European Economic Area under the names:<\/strong><\/th><\/tr><\/thead> Denmark<\/td> Navirel 10 mg \/ ml concentrate for solution for infusion<\/td><\/tr> Finland<\/td> Navirel 10 mg \/ ml infusioconcentraatti, liuosta varten<\/td><\/tr> Netherlands<\/td> Navirel 10 mg \/ ml concentrate for solution for infusion<\/td><\/tr> Norway<\/td> Navirel 10 mg \/ ml concentrate for solution for infusion<\/td><\/tr> Poland<\/td> Navirel<\/td><\/tr> Portugal<\/td> Vinorelbina Navirel 10 mg \/ ml concentrated for perfusion solution<\/td><\/tr> Slovakia<\/td> Navirel 10 mg \/ ml infusion concentrate<\/td><\/tr> Sweden<\/td> Navirel 10 mg \/ ml concentrate for solution for infusion<\/td><\/tr> Czech Republic<\/td> Navirel 10 mg \/ ml concentrate for solution for infusion<\/td><\/tr> Germany<\/td> Navirel 10 mg\/ml concentrate for the preparation of an infusion solution<\/td><\/tr><\/tbody><\/table><\/figure>\n","protected":false},"excerpt":{"rendered":"